Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign multiple sclerosis.

S Glad1, H Nyland, K-M Myhr

  • 1Multiple Sclerosis National Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway. solveig.bergloit.glad@helse-bergen.no

Acta Neurologica Scandinavica. Supplementum
|April 28, 2006
PubMed
Summary

A small fraction of multiple sclerosis (MS) patients experience a benign disease course. Current definitions focus on physical ability, but non-motor symptoms like fatigue and pain significantly impact quality of life and should be included.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial.

Multiple sclerosis journal - experimental, translational and clinical·2019
Same author

The economic impact of multiple sclerosis to the patients and their families in Norway.

The European journal of health economics : HEPAC : health economics in prevention and care·2018
Same author

Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy.

European journal of neurology·2017
Same author

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.

European journal of neurology·2016
Same author

Disease-modifying treatments for multiple sclerosis - a review of approved medications.

European journal of neurology·2015
Same author

Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study.

European journal of neurology·2015

Area of Science:

  • Neurology
  • Clinical Medicine
  • Neuroimmunology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease.
  • A subset of MS patients exhibits a benign clinical course.
  • Current definitions of benign MS primarily assess motor function and ambulation.

Purpose of the Study:

  • To challenge the traditional definition of benign multiple sclerosis.
  • To advocate for the inclusion of non-motor symptoms in defining benign MS.
  • To highlight the impact of non-motor symptoms on patient disability.

Main Methods:

  • Review of existing literature on benign MS definitions.
  • Analysis of patient-reported outcomes focusing on non-motor symptoms.
  • Comparison of ambulatory status versus overall disability in MS patients.

Related Experiment Videos

Main Results:

  • Many fully ambulatory MS patients report significant disability from non-motor symptoms.
  • Fatigue, pain, depression, and cognitive dysfunction are prevalent.
  • These symptoms are often overlooked in traditional assessments of benign MS.

Conclusions:

  • The definition of benign MS requires re-evaluation.
  • Non-motor symptoms are critical indicators of disability in MS.
  • A comprehensive definition of benign MS must incorporate both motor and non-motor aspects.